Login / Signup

The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants.

Michal Ariela RazJon ArnasonOsnat BaireyLev ShvidelAriel AvivSharon Ben BaruchChava PerryNadav SaridIlya KirgnerVaron DvidYair HerishanuIrit Avivi
Published in: British journal of haematology (2020)
Keyphrases
  • direct oral anticoagulants
  • atrial fibrillation
  • venous thromboembolism
  • chronic lymphocytic leukemia